Terms: = Ovarian cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Prognosis
73 results:
1. CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
Luo X; Mo J; Zhang M; Huang W; Bao Y; Zou R; Yao L; Yuan L
World J Surg Oncol; 2024 Feb; 22(1):44. PubMed ID: 38317230
[TBL] [Abstract] [Full Text] [Related]
2. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, he4, and C5a.
Shi H; Liu L; Deng X; Xing X; Zhang Y; Djouda Rebecca Y; Han L
J Ovarian Res; 2024 Jan; 17(1):4. PubMed ID: 38178252
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic value of he4 in advanced-stage, high-grade serous ovarian cancer: Analysis of he4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.
AlSomairi A; Himayda S; Altelmesani A; Lee YJ; Lee JY
Gynecol Oncol; 2024 Feb; 181():155-161. PubMed ID: 38176127
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
Wang H; Chen C; Wang D; Zhu Y; Chen P
BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of prediction model for early warning of ovarian metastasis risk of endometrial carcinoma.
Zhao Q; Li Y; Wang T
Medicine (Baltimore); 2023 Oct; 102(41):e35439. PubMed ID: 37832099
[TBL] [Abstract] [Full Text] [Related]
6. A predictive and prognostic model for surgical outcome and prognosis in ovarian cancer computed by clinico-pathological and serological parameters (CA125, he4, mesothelin).
Klotz DM; Link T; Wimberger P; Kuhlmann JD
Clin Chem Lab Med; 2024 Feb; 62(3):530-539. PubMed ID: 37816681
[TBL] [Abstract] [Full Text] [Related]
7. Recent Insight about he4 Role in ovarian cancer Oncogenesis.
Anastasi E; Farina A; Granato T; Colaiacovo F; Pucci B; Tartaglione S; Angeloni A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445657
[TBL] [Abstract] [Full Text] [Related]
8. An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China.
Chen S; Lu H; Jiang S; Li M; Weng H; Zhu J; Zhang T; Wang Y; Zhao W; Wu D; Shen Z; Yang Z; Zhou Y
BMC Cancer; 2023 Jul; 23(1):608. PubMed ID: 37391693
[TBL] [Abstract] [Full Text] [Related]
9. Clinical value of serum and tissue AGR2 for diagnosis and prognosis in epithelial ovarian cancer.
Yan T; Wang H; Ma X; Cao J; Tong Y; Guo L; Lu R
Biomark Med; 2023 Mar; 17(6):325-336. PubMed ID: 37284743
[No Abstract] [Full Text] [Related]
10. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract] [Full Text] [Related]
11. Measurement of he4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancer.
Kotowicz BU; Fuksiewicz M; Bidzinski M; Berezowska A; Sobiczewski P; Kowalska MM
Ginekol Pol; 2022; 93(11):910-915. PubMed ID: 36621970
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of the clinical characteristics and prognosis between clear cell carcinomas and high-grade serous ovarian carcinomas.
Dong S; Yu F; Liu Y; Yu X; Sun X; Wang W; Wang Y
Ginekol Pol; 2023; 94(10):792-798. PubMed ID: 36477777
[TBL] [Abstract] [Full Text] [Related]
13. Molecular Biomarkers for the Early Detection of ovarian cancer.
Zhang R; Siu MKY; Ngan HYS; Chan KKL
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233339
[TBL] [Abstract] [Full Text] [Related]
14. Elevated serum level of human epididymal protein 4 (he4) predicts poor prognosis in the critically ill with sepsis: A prospective observational cohort study.
Lai X; Kang M; Chen Y; Xu F; Wang K; Cao J
Clin Biochem; 2022; 109-110():79-85. PubMed ID: 35932794
[TBL] [Abstract] [Full Text] [Related]
15. [Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer].
Li Z; Cai XW; Yan P; Zhou D; He MM; Deng L; Wang YZ; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):190-197. PubMed ID: 35385956
[No Abstract] [Full Text] [Related]
16. Exposure to polycyclic aromatic hydrocarbons and its relationship with increased expression of human epididymal secretory protein 4.
Liang HI; Cheng YW; Chang HS; Su KM; Chen WL
Pol Arch Intern Med; 2022 Apr; 132(4):. PubMed ID: 35044732
[TBL] [Abstract] [Full Text] [Related]
17. Nomogram of Combining CT-Based Body Composition Analyses and Prognostic Inflammation Score: Prediction of Survival in Advanced Epithelial ovarian cancer Patients.
Wang X; Zhang C; Cao F; Wang CB; Dong JN; Wang ZH
Acad Radiol; 2022 Sep; 29(9):1394-1403. PubMed ID: 34955366
[TBL] [Abstract] [Full Text] [Related]
18. Fluorescence turn-on immunosensing of he4 biomarker and ovarian cancer cells based on target-triggered metal-enhanced fluorescence of carbon dots.
Han C; Chen R; Wu X; Shi N; Duan T; Xu K; Huang T
Anal Chim Acta; 2021 Dec; 1187():339160. PubMed ID: 34753571
[TBL] [Abstract] [Full Text] [Related]
19. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial ovarian cancer Through the p38 MAPK Pathway.
Gao J; Zhu L; Zhuang H; Lin B
Adv Ther; 2022 Jan; 39(1):360-378. PubMed ID: 34739698
[TBL] [Abstract] [Full Text] [Related]
20. Serum he4 is associated with clinical prognostic factors and survival outcome in female patients with primary peritoneal carcinoma.
Mi D; Zhang Y; Chen S
Int J Gynaecol Obstet; 2022 Aug; 158(2):352-358. PubMed ID: 34735726
[TBL] [Abstract] [Full Text] [Related]
[Next]
